Regimen | No. (%) of treatments* |
---|---|
Transdermal estrogen | 48 846 (62.3) |
Without progestagen | 9 488 (12.1) |
With progesterone | 20 534 (26.2) |
With pregnane derivative | 6 449 (8.2) |
With norpregnane derivative | 11 370 (14.5) |
With testosterone derivative | 518 (0.7) |
With other progestagen | 487 (0.6) |
Oral estrogen | 22 880 (29.2) |
Estradiol | 21 498 (27.4) |
Without progestagen | 1 713 (2.2) |
With progesterone | 4 940 (6.3) |
With pregnane derivative | 7 121 (9.1) |
With norpregnane derivative | 2 775 (3.5) |
With testosterone derivative | 4 822 (6.1) |
With other progestagen | 127 (0.2) |
Oral equine estrogen | 1 382 (1.8) |
Without progestagen | 585 (0.7) |
With progesterone | 219 (0.3) |
With pregnane derivative | 311 (0.4) |
With norpregnane derivative | 193 (0.2) |
With testosterone derivative | 45 (0.1) |
With other progestagen | 29 (0.04) |
Other estrogen | 6 709 (8.6) |
↵* Each course of menopausal hormone therapy is counted separately. The total courses of treatment was 78 435 among 45 984 women.